Medlab Clinical updates on progress towards phase 3 trial
Medlab Clinical (ASX:MDC) says it has received ‘Favourable Opinion’ status from the UK Research Ethics Committee for the forthcoming NanaBis Phase 3
Source: miragenews.com
Stay updated with breaking news from Australian Ethics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Medlab Clinical (ASX:MDC) says it has received ‘Favourable Opinion’ status from the UK Research Ethics Committee for the forthcoming NanaBis Phase 3